Rv3794 - c.-5G>T
Drug resistance types
10 Sensitive
0 RR-TB
0 HR-TB
9 MDR-TB
9 Pre-XDR-TB
2 XDR-TB
2 Other
lineage Counts
| lineage | Count |
|---|---|
| lineage4.9 | 12 |
| lineage2.2.1 | 3 |
| lineage4.1.2.1 | 15 |
| lineage3 | 1 |
| lineage2.2.1;lineage4 | 1 |
spoligotype Counts
| spoligotype | Count |
|---|---|
| None | 32 |
Geographic prevalence
Country level data for this variant is available for 0 isolates.
Statisctical support
Not enough data to calculate support.
Samples
| ID | Drug resistance | Lineage | Country iso2 | SRR13837932 | Sensitive | lineage4.9 | None | SRR13837423 | Sensitive | lineage4.9 | None | SRR29274764 | Pre-XDR-TB | lineage2.2.1 | None | SRR29273673 | Pre-XDR-TB | lineage4.1.2.1 | None | SRR29274029 | MDR-TB | lineage4.1.2.1 | None | SRR28044347 | XDR-TB | lineage3 | None | SRR28646078 | MDR-TB | lineage4.1.2.1 | None | SRR25827561 | Pre-XDR-TB | lineage2.2.1;lineage4 | None | SRR13861362 | Other | lineage4.9 | None | SRR29341531 | Pre-XDR-TB | lineage4.1.2.1 | None | ERR13265180 | MDR-TB | lineage2.2.1 | None | SAMN02231158 | MDR-TB | lineage4.1.2.1 | ml | SRR1162745 | MDR-TB | lineage4.1.2.1 | None | SRR5486902 | MDR-TB | lineage4.1.2.1 | None | SRR1162476 | MDR-TB | lineage4.1.2.1 | None | SRR13861723 | Sensitive | lineage4.9 | None | SRR13838008 | Sensitive | lineage4.9 | None | SRR13861555 | Other | lineage4.9 | None | SRR29273630 | Pre-XDR-TB | lineage4.1.2.1 | None | SRR13837658 | Sensitive | lineage4.9 | None | SRR13837451 | Sensitive | lineage4.9 | None | SRR29274107 | MDR-TB | lineage4.1.2.1 | None | SRR13861722 | Sensitive | lineage4.9 | None | SRR29273829 | XDR-TB | lineage4.1.2.1 | None | SRR10525375 | Pre-XDR-TB | lineage4.1.2.1 | None | SRR7585404 | Pre-XDR-TB | lineage2.2.1 | in | SRR29274093 | Pre-XDR-TB | lineage4.1.2.1 | None | SRR13837434 | Sensitive | lineage4.9 | None | SRR13861527 | Sensitive | lineage4.9 | None | SRR29273691 | Pre-XDR-TB | lineage4.1.2.1 | None | SRR29273979 | MDR-TB | lineage4.1.2.1 | None | SRR13837450 | Sensitive | lineage4.9 | None |
|---|
